Detection and interpretation of altered methylation patterns in cancer cells
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumour types. New techniques have been developed to perform genome-wide screening for alterations in DNA-methylation patterns, not only to identify tumour-suppressor genes, but also to find patterns that can be used in diagnosis and prognosis. However, interpretation of differential methylation has proven difficult because the significance of methylation alterations depends on the genomic region, and functions of CpG islands at specific sites have not been fully clarified. What techniques can be used to identify new tumour suppressors and diagnostic markers?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS influence the activity of epigenetic modulators, such as histone deacetylases (HDACs) or DNA methyltransferases (DNMTs) with consequences that are evident in the expression of the target genes38,39.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [39]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746 · cited 1×
“), and defines regions for transcriptional regulatio”
Cited by
Items 301–400 of 482
Kwon, J., Park, M., Kim, J.-H., Lee, H. W., Kang, M. C., & Park, J. H. (2015) · Tumor Biology · doi:10.1007/s13277-015-3443-x · Cited by 16
“DNA methylation is a key mechanism for inhibiting the expression of tumor suppressor genes and other genes involved in tumor progression [6].”
BackgroundAberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer
Khalaj‐Kondori, M., Hosseinnejad, M., Hosseinzadeh, A., Sharif, S. B., & Hashemzadeh, S. (2019) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.03.001 · Cited by 16
Moriguchi, K., Yamashita, S., Tsujino, Y., Tatematsu, M., & Ushijima, T. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.014 · Cited by 16
Self-citationMolecular targets in gynaecological cancers
Cheung, A. (2007) · Pathology · doi:10.1080/00313020601153273 · Cited by 18
“High throughput assays such as differential methylation microarrays are available for such investigation.(198) Moreover, DNA is more stable than RNA, and methylation biomarkers can be detected in patient serum and other body fluids.”
BackgroundUtilizing Gold Nanoparticle Probes to Visually Detect DNA Methylation
Chen, K., Zhang, M., Chang, Y., Xia, L. H., Gu, W., Qin, Y., Li, J., Cui, S., & Xing, G. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1487-5 · Cited by 15
“To date, numerous techniques have been developed for DNA methylation detection [7, 8].”
MethodThe role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancer
Lee (2010) · Oncology Reports · doi:10.3892/or_00000811 · Cited by 15
ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions
Juan, Y., Su, Y., Bai, C., Fan, Y., Kuo, T., Ko, H., Peng, H., Chiang, C., Fwu, C., & Cheng, S. (2021) · Oral Diseases · doi:10.1111/odi.13946 · Cited by 17
Raut, J. R., Guan, Z., Schrotz‐King, P., & Brenner, H. (2019) · Cancers · doi:10.3390/cancers11070912 · Cited by 15
“As methylation patterns often vary largely across genomic regions and are poorly defined [53,54], the analysis of a limited number of CpG dinucleotides is less informative compared to a genome-wide analysis.”
BackgroundCell type-dependent, infection-induced, aberrant DNA methylation in gastric cancer
Perrin, D., Ruskin, H. J., & Niwa, T. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.02.040 · Cited by 21
“This is sometimes referred to as driver methylation, because of causal involvement in carcinogenesis, (as opposed to passenger methylation, which refers to genes whose methylation is a consequence of cancer development, and therefore requires careful analysis of newly detected genes (Ushijima, 2005)).”
BackgroundSano, A., Kage, H., Sugimoto, K., Kitagawa, H., Aki, N., Goto, A., Fukayama, M., Nakajima, J., Takamoto, S., Nagase, T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210483 · Cited by 15
“DNA methylation, especially the methylation of cytosine of the CpG dinucleotide clustered in the promoter region of genes (CpG islands; recent characterization and definition is described in Takai and Jones, 2002), is known to regulate gene expression in normal development such as X-chromosome inactivation (Panning an…”
BackgroundTakeshima, H., Yamashita, S., Shimazu, T., & Ushijima, T. (2011) · Genomics · doi:10.1016/j.ygeno.2011.06.003 · Cited by 14
Self-citationDNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation.
Рифкатовна, М. Р., Sandberg, T., Hedblom, A., Nevzorova, T., Persson, J. L., & Bredberg, A. C. A. (2012) · PubMed · Cited by 14
LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
Tian, M., Liu, W., Jin, L., Jiang, X., Yang, L., Ding, Z., Shen, Y., Peng, Y., Gao, D., Li, L., et al. (2015) · Europe PMC (PubMed Central) · Cited by 14
Wang, Y., Chen, Y., Li, X., Hu, W., Zhang, Y., Chen, L., Chen, M., & Chen, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4449-8 · Cited by 14
“The deficiency of α-internexin was confirmed to be associated with malignant biological behaviors [5, 6, 14].”
Ma, J., Xia, L., Yao, X., Zheng, S., Shi, L., Xu, L., Sha, W., & Li, Z. (2020) · Oncology Reports · doi:10.3892/or.2020.7558 · Cited by 17
“DNA methylation within the promoter of tumor-suppressor genes, which is commonly found in cancer cells, leads to transcriptional silencing, and subsequently promotes cancer development (25).”
BackgroundInfluence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer
Mathebela, P., Damane, B. P., Mulaudzi, T. V., Mkhize‐Kwitshana, Z. L., Gaudji, G. R., & Dlamini, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213750 · Cited by 16
Li, Y., Tan, T., Zong, L., He, D., Tao, W., & Liang, Q. (2012) · Chromosome Research · doi:10.1007/s10577-012-9311-2 · Cited by 15
Tan, J., Gu, Y., Zhang, X., You, S., Lu, X., Chen, S., Han, X., & Sun, Y. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0173-2 · Cited by 13
“Secondly, SINE/alu repetitive sequences were excluded from CpG islands according to a new strict criterion for CpG island [26].”
MethodDNA Methylation-Based Fecal Biomarkers for the Noninvasive Screening of GI Cancers
Goel, A. (2010) · Future Oncology · doi:10.2217/fon.10.9 · Cited by 13
Surfactant protein DNA methylation: A new entrant in the field of lung cancer diagnostics? (Review)
Floros (1994) · Oncology Reports · doi:10.3892/or_00000182 · Cited by 14
“The first step in developing a panel of DNA methylation biomarkers is to identify patterns of tumor methylation signatures (71).”
Yoon, H. Y., Kim, Y., Kim, J. S., Kim, Y., Kang, H. W., Kim, W. T., Yun, S. J., Ryu, K. H., Lee, S., & Kim, W. (2015) · Oncology Reports · doi:10.3892/or.2015.4409 · Cited by 13
Zhao, R., Zhou, J., He, J., Wei, Y., Qin, Y., & Li, B. (2016) · PubMed · Cited by 13
Establishment of a high-throughput detection system for DNA demethylating agents
Okochi‐Takada, E., Hattori, N., Ito, A., Niwa, T., Wakabayashi, M., Kimura, K., Yoshida, M., & Ushijima, T. (2016) · Epigenetics · doi:10.1080/15592294.2016.1267887 · Cited by 13
Self-citationXu, X., Chang, X., Xu, Y. H., Deng, P., Wang, J., Zhang, C., Zhu, X.-J., Chen, S., & Dai, D. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01647-4 · Cited by 15
Drini, M., Wong, N. C., Scott, H. S., Craig, J. M., Dobrovic, A., Hewitt, C., Christofer, D., Young, J. P., Jenkins, M. A., Saffery, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016831 · Cited by 12
“In comparison with non-diseased tissue, human cancers generally show variations in both global DNA methylation (hypomethylation) and gene-specific (hyper- or hypo methylation) status [16,57].”
BackgroundInduced pluripotent stem cell technology for dissecting the cancer epigenome
Semi, K., & Yamada, Y. (2015) · Cancer Science · doi:10.1111/cas.12758 · Cited by 14
Wu, D., Chen, X., Xu, Y., Wang, H., Yu, G., Jiang, L., Hong, Q., & Duan, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.5759 · Cited by 12
“DNA methylation is as a key mechanism in the inhibition of the expression of tumor suppressor genes (12).”
Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma
Xia, L., Zhu, Y., Zhang, C., Deng, S., Deng, Y., Yang, Z., Mei, J., & Liu, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.41 · Cited by 12
Xu, H., Huang, K., Lin, Y., Gong, H., Ma, X., & Zhang, D. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01559-y · Cited by 14
“Aberrant DNA methylation of a promoter CpG island, as a hallmark of cancer, can induce altered or dysregulated gene expression during tumorigenesis and is associated with cancer progression and prognosis [74, 75].”
BackgroundHu, J., Chen, Y., Xu, X., Wu, F., Xing, X., Xu, Z., Xu, J., Weng, X., & Zhou, X. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.017 · Cited by 12
CpG island mapping by epigenome prediction
Bock, C., Walter, J. E., Paulsen, M., & Lengauer, T. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030110.eor · Cited by 13
Advances in Epigenomic Sequencing and Their Applications in Cancer Diagnostics
Lin, L., & Liu, Y. (2025) · Precision Chemistry · doi:10.1021/prechem.5c00014 · Cited by 12
PTENhypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma
Pan, Q. F., Li, W. T., Dong, H. C., Chen, Y. Z., Yin, L., Liu, W., Wang, W. W., Liu, D., Li, S. G., Gu, W., et al. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12106 · Cited by 11
Kim, Y., Yoon, H.-Y., Seo, S. P., Lee, S. K., Kang, H. W., Kim, W. T., Bang, H. J., Ryu, D. H., Yun, S.-J., 이상철, et al. (2015) · Disease Markers · doi:10.1155/2015/402963 · Cited by 11
“The epigenetic silencing of tumor suppressor genes may be relevant clinically because epigenetic changes may be reversible and thus restore gene function [4, 5, 7].”
Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
Payne, K. K., Toor, A. A., Wang, X., & Manjili, M. H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/760965 · Cited by 13
“Aberrant CTA expression likely occurs due to epigenetic molecular alterations which arise during tumor progression; cancer cells display drastic changes in DNA methylation status, typically exhibiting global DNA hypomethylation as well as region-specific hypermethylation [58], resulting in irregular expression of CTAs.”
BackgroundHe, Y., Zhao, Y., Zhang, S., Chen, W., Lin, S., Yang, Q., Liu, J., Yang, Y., Jin, Y., & Liu, M. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.08.012 · Cited by 11
Interaction between DNMT1 and DNA replication reactions in the SV40 in vitro replication system
Shimamura, S., & Ishikawa, F. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00913.x · Cited by 12
Ferreira, W. A. S., Vitiello, G. A. F., Medina, T. D. S., & de Oliveira, E. H. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-10114-1 · Cited by 12
Epigenetic Changes in Tumor Suppressor Genes, P15, P16, APC‐3 and E‐cadherin in Body Fluid
Chen, M., Chang, J. H., Yeh, K., Chang, Y., & Chang, J. (2007) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(08)70007-x · Cited by 11
Tahara, T., & Arisawa, T. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.38 · Cited by 13
Yang, C., Su, Y., Cheng, H., Juan, Y., Chiu, Y., Wu, C., Chen, P.-Y., Lee, Y.-H., Chen, Y., Chen, Y., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12071544 · Cited by 10
“tumor suppressor genes or regulatory regions within the genome, leading to cell growth dysregulation or altered responses to cancer therapies [23,24].”
BackgroundLee, J., Kim, K. S., Lee, M. H., Kim, Y. S., Lee, M. H., Lee, S. E., Kim, Y. K., Ryu, M. J., Kim, S. J., Choi, M. J., et al. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.5.1158 · Cited by 10
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples
Miyamoto, S., Watanabe, Y., Oikawa, R., Ono, S., Mabe, K., Kudo, T., Yamamoto, H., Itoh, F., Kato, M., & Sakamoto, N. (2016) · Tumor Biology · doi:10.1007/s13277-016-4886-4 · Cited by 10
Passenger mutations in cancer evolution
Aparisi, F., Labrador, H. A., Fariñas, S. C., Torres‐Martínez, S., Herreros‐Pomares, A., Lewintre, E. J., Blasco, A. V., Iranzo, V., & Camps, C. (2019) · Cancer Reports and Reviews · doi:10.15761/crr.1000188 · Cited by 14
“Global DNA hypomethylation and gene-specific hypermethylation are among the prominent hallmarks of cancer genomes [38].”
BackgroundLi, T., Guo, X., Wang, W., Mo, X., Wang, P., & Han, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2785 · Cited by 10
“This therefore confirmed that epigenetic modifications were an important mechanism in the regulation of VSTM1 , which may be of use as a promising novel diagnostic and prognostic genetic marker for hematopoietic malignancies (27).”
Hugwil, A. V. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.05.037 · Cited by 10
“A conspicuous finding on cancer cell epigentics is that most of all tumor suppressor genes are methylated and thus the function of those genes are epigenetically repressed without DNA sequence change [14].”
BackgroundSugito, K., Kawashima, H., Uekusa, S., Yoshizawa, S., Hoshi, R., Furuya, T., Kaneda, H., Hosoda, T., Masuko, T., Ohashi, K., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24282 · Cited by 10
Iglesias, T., Espina, M., Montes‐Bayón, M., Sierra, L. M., & Blanco‐González, E. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8070-7 · Cited by 10
Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis
Yu, G., Lai, C., Xu, Y., Bu, C., & Su, Z. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.11.4665 · Cited by 10
“If hypermethylation occur in a tumor-suppressor gene promoter, its downstream genes are consistently inactivated which leading to tumor development and progression (Ushijima, 2005).”
BackgroundGu, Y., Tan, J., Lu, X., Ding, Y., Han, X., & Sun, Y. (2008) · Oncology · doi:10.1159/000139125 · Cited by 10
“DNA methylation is an important regulator of gene transcription, and its role in carcinogenesis has been the hot spot of cancer research in recent years. However, the effects of methylation alterations not only depend on the genomic region where methylation alteration occurs [”
BackgroundDefining the chromatin landscape in demyelinating disorders
Huynh, J. L., & Casaccia, P. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.014 · Cited by 11
“Similarly, methylation adjacent to a gene does not necessarily silence it, as it is usually a specific core region of the promoter that must be hypermethylated to turn off gene expression (Ushijima, 2005).”
PKNOX2 suppresses lung cancer cell proliferation by inhibiting the PI3K/AKT/mTOR axis
Song, M., Zhang, N., Cao, F.-M., & Liu, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11917 · Cited by 9
“Among the epigenetic alterations, the abnormal DNA methylation of promoter CpG islands can repress the transcription of down‑ stream genes, and tumor suppressor genes can be inactivated through this mechanism (23).”
Kageyama, S., Shinmura, K., Yamamoto, H., Goto, M., Suzuki, K., Tanioka, F., Tsuneyoshi, T., & Sugimura, H. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn021 · Cited by 9
Methylation-Sensitive Representational Difference Analysis (MS-RDA)
Ushijima, T., & Yamashita, S. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-522-0_10 · Cited by 9
Self-citationPadín-Iruegas, E., Chamorro-Petronacci, C. M., Sines-Cajade, I., Lorenzo‐Pouso, A. I., Carrión, A. B., Jardón, A. P., Vila, P. G., & Pérez‐Sayáns, M. (2022) · Medicina · doi:10.3390/medicina58070878 · Cited by 9
“Methylation of this promoter is a key predictor of whether alkylating agents can effectively control tumor cell progression [11].”
BackgroundNagasaka, T., Goel, A., Matsubara, N., & Tanaka, N. (2006) · PubMed · doi:10.18926/amo/30741 · Cited by 9
Inhibition of DNA Methylation at the MLH1 Promoter Region Using Pyrrole–Imidazole Polyamide
Shinohara, K., Yoda, N., Takane, K., Watanabe, T., Fukuyo, M., Fujiwara, K., Kita, K., Nagase, H., Nemoto, T., & Kaneda, A. (2016) · ACS Omega · doi:10.1021/acsomega.6b00229 · Cited by 9
Analysis of DNA Methylation in Tissues Exposed to Inflammation
Hattori, N., & Ushijima, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7568-6_16 · Cited by 9
Self-citationTang, J. T., Wang, Z., & Fang, J. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s91941 · Cited by 8
Teng, J.-J., Zhao, W., Zhang, X., Zhao, D., Qiu, X., Chen, X., & Yang, L. (2021) · Journal of Cancer · doi:10.7150/jca.59998 · Cited by 8
“In epigenetic changes, abnormal DNA methylation of a promoter CpG Island (CGI) can continuously inhibit the transcription of its downstream genes, and tumor suppressor genes can be inactivated by this mechanism [16].”
BackgroundYoon, H. Y., Kim, Y., Kang, H. W., Kim, W. T., Yun, S. J., Lee, S., Kim, W., & Kim, Y. (2013) · Korean journal of urology · doi:10.4111/kju.2013.54.3.194 · Cited by 8
“Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumor types [2-4].”
BackgroundInfluentialMethylation of AKAP12{alpha} promoter in lung cancer.
Jo, U., Whang, Y. M., Sung, J. S., & Kim, Y. H. (2010) · PubMed · Cited by 8
Kim, Y., Jang, W., Piao, X., Yoon, H. Y., Byun, Y. J., Kim, J., Kim, S. H., Lee, S., Seo, S., Kang, H. W., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7151 · Cited by 9
Chaudhari, S., Kamata, T., Kojima, N., Sumimoto, M., Satyamoorthy, K., Kurita, R., & Kato, D. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128092 · Cited by 8
Watanabe, N., Okochi‐Takada, E., Yagi, Y., Furuta, J., & Ushijima, T. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_10 · Cited by 8
Self-citationMolecular Techniques for DNA Methylation Studies
Tost, J., & Gut, I. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802971-8.00007-9 · Cited by 9
Wu, S., Zhang, Y., Zhang, L., Ma, J., Zhou, T., Li, Z., Liu, W., Li, W., You, W., & Pan, K. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0119 · Cited by 7
Methylation level of Rap1GAP and the clinical significance in MDS
Ding, W., Yang, Y., Chen, Z., Wang, Y., Dong, W., Cen, J., Qi, X., Jiang, F., & Chen, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9503 · Cited by 7
“Among these alterations, methylation of the tumor suppressor gene promoter results in gene silencing, which often take place during the early stages of tumor development (4).”
Xia, N., & Hao, Y. (2019) · International Journal of Electrochemical Science · doi:10.20964/2019.02.32 · Cited by 7
High rate of mutation reporter gene inactivation during human T cell proliferation
Gabdoulkhakova, A. G., Henriksson, G., Avkhacheva, N. V., Sofin, A. D., & Bredberg, A. C. A. (2006) · Immunogenetics · doi:10.1007/s00251-006-0180-8 · Cited by 7
“Recently, two groups have presented evidence for a ‘seeding’ two-step mechanism operating during epigenetic gene silencing (Stirzaker et al. 2004; Ushijima 2005).”
BackgroundOrta, M. L., Mateos, S., & Cortés, F. (2009) · Mutagenesis · doi:10.1093/mutage/gep002 · Cited by 7
Baylin, S. B. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10005-6 · Cited by 11
Evaluation of three mRNA markers for the detection of lymph node metastases.
Berger, J., Mueller‐Holzner, E., Fiegl, H., Marth, C., & Daxenbichler, G. (2006) · PubMed · Cited by 7
Advances in the molecular genetics of acute leukemia
Scandura, J. M. (2005) · Current Oncology Reports · doi:10.1007/s11912-005-0058-1 · Cited by 7
Huang, Q. Y., Huang, J.-F., Zhang, B., Baum, L., & Fu, W. (2012) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e318230effd · Cited by 7
“These epigenetic biomarkers have been considered as indicators for the diagnosis, prognosis, or risk assessment of human diseases, especially human cancers.(9) Considering the epigenetic information obtained from various analysis methodologies for DNA methylation, only MVP profiles can accurately reflect the presence…”
BackgroundInfluentialCHP2 gene expression and quantitation in Egyptian patients with acute leukemia
Hammam, A. A., Eissa, H. H., Masry, M. R. E., & Mahmoud, S. A. M. (2014) · Meta Gene · doi:10.1016/j.mgene.2014.04.001 · Cited by 6
“…collection of diseases whose initiation and progression are promoted by the aberrant function of genes that regulate DNA repair, genome stability, cell proliferation, cell death, adhesion, angiogenesis, invasion, and metastasis in complex cell and tissue microenvironments (Ushijima, 2005).”
BackgroundAnalysis of O6-methylguanine-DNA methyltransferase methylation status in sporadic colon polyps
Kycler, W., Szarzyńska‐Zawadzka, B., Łoziński, C., Korski, K., & Lamperska, K. M. (2012) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2011.11.002 · Cited by 7
Serpi, C., Voulgaropoulos, A., & Girousi, S. T. (2013) · Electroanalysis · doi:10.1002/elan.201200610 · Cited by 6
Novel Tools for Unbiased Dna Differential Methylation Screening
Tanas, A. S., Shkarupo, V., Kuznetsova, E., Zaletaev, D. V., & Strelnikov, V. V. (2010) · Epigenomics · doi:10.2217/epi.10.3 · Cited by 6
Analysis of Gene-Specific DNA Methylation
Hattori, N., & Ushijima, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805388-1.00008-0 · Cited by 6
Self-citationPapatheodoridi, A. M., Chatzigeorgiou, A., Chrysavgis, L., Lembessis, P., Loglio, A., Facchetti, F., Cholongitas, Ε., Koutsilieris, M., Lampertico, P., & Papatheodoridis, G. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13446 · Cited by 7
Fluorimetric detection of DNA methylation by cerium oxide nanoparticles for early cancer diagnosis
Adampourezare, M., Nikzad, B., Amini, M., & Sheibani, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28695 · Cited by 5
Santourlidis, S., Araúzo-Bravo, M. J., Brodell, R. T., Hassan, M., & Bendhack, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137331 · Cited by 5
“When methylated, certain CpG dinucleotide locations influence gene silence more than others [35].”
BackgroundLi, Y., Liu, B., Zhou, X., Yang, H., Han, T., Hong, Y., Wang, C., Huang, M., Shi, Y., Li, S., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.24.00111 · Cited by 7
DNA methylation of mobile genetic elements in human cancers
Han, K., Lee, J., Km, H.-S., Yang, K., & Yi, J. M. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0095-3 · Cited by 6
“Genome-wide DNA hypomethylation and gene-specific hypermethylation of CpG islands are prominent hallmarks of cancer genomes (Ehrlich 2002; Ushijima 2005).”
Jazii, R. (2011) · Journal of sciences, Islamic Republic of Iran · doi:10.22059/jsciences.2011.23584 · Cited by 5
“Also, different CGIs and, even within them, different regions show different susceptibility to aberrant DNA methylation [55].”
BackgroundAnalysis of Genome-Wide DNA Methylation Profiles by BeadChip Technology
Lin, Q., Wagner, W., & Zenke, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_3 · Cited by 4
DNA‐Based Nanoprobes for Simultaneous Detection of Telomerase and Correlated Biomolecules
Liu, W., Fan, Z., Li, L., & Li, M. (2022) · ChemBioChem · doi:10.1002/cbic.202200307 · Cited by 5
Hiura, H., Okae, H., Kobayash, H., Miyauchi, N., Sato, F., Satô, A., Suzuki, F., Nagase, S., Sugawara, J., Nakai, K., et al. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-8 · Cited by 5
“DNA methylation offers an additional tool that can be used in combination with other markers [29].”
MethodPerinatal Exposure to Environmental Chemicals Induces Epigenomic Changes in Offspring
Ohsako, S. (2011) · Genes and Environment · doi:10.3123/jemsge.33.43 · Cited by 4
Analysis of Gene-specific DNA Methylation
Hattori, N., & Ushijima, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375709-8.00008-3 · Cited by 4
Self-citationSingi, P., Rocha, R. P., de Carli, M. L., Hanemann, J. A. C., Pereira, A. A. C., Coelho, L. F. L., & Malaquias, L. C. C. (2019) · Mycoses · doi:10.1111/myc.13000 · Cited by 5
The Mechanisms of Epigenetic Modifications During DNA Replication
Kubota, T., Miyake, K., & Hirasaw, T. (2013) · InTech eBooks · doi:10.5772/51592 · Cited by 7
“This definition is now associated with in a wide variety of bio‐ logical processes, such as genomic imprinting [3,4], inactivation of the X chromosome [5], embryogenesis [6], tissue differentiation [7], and carcinogenesis [8].”
BackgroundHosoda, K., Yashima, K., Tamoto, A., Yamamoto, S., Kawata, S., Ikebuchi, Y., Matsumoto, K., Kawaguchi, K., Harada, K., Murawaki, Y., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6196 · Cited by 4
“The role of epigenetic changes, including aberrant DNA methylation, is particularly significant in human cancer development (9,10).”
Electronic properties for detection of DNA methylation
Tian, Y., Liu, Z., Cheng, Y., & Liu, H. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1324/1/012052 · Cited by 4
“However, many studies have founded that DNA abnormal methylations are more common and important in the process of tumorigenesis [4], such as breast cancer, ovarian cancer, gastric cancer, colon cancer, bladder cancer and liver cancer [5,6].”
BackgroundIdentification of Imprinted Genes and Their Differentially Methylated Regions in Porcine
Yin, Z., Zhang, X., Li, J., Jiao, Y., Kong, Q., & Mu, Y. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419120135 · Cited by 3
“DMRs with allele specific methylation can be used in cancer diagnosis [15, 16].”
The diagnostic value of methylated DNA in laryngeal squamous cell carcinoma: meta-analysis
Li, Z., Gao, W., Lei, W., Ho, W., Chan, Y., & Wong, T. (2013) · Head & Neck Oncology · Cited by 3
Aslam, M., Shaeer, A., Abbas, Z., Ahmed, A., Gull, I., & Athar, M. A. (2016) · Technology in Cancer Research & Treatment · doi:10.1177/1533034616682155 · Cited by 5
“Also amplification of DNA methylation can be easily performed via PCR even if extracted DNA concentration is low.(43,44) So it can serve as the promising biomarker for cancer detection.”
BackgroundBaylin, S. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00005-6 · Cited by 4
Liao, A., Su, Q., Wang, X., Zeng, B., & Shi, W. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1333 · Cited by 3
Metadata
- Authors
- Ushijima, T.
- Affiliations
- National Cancer Center Research Institute (JP)
- Corresponding author
- Ushijima, Toshikazu
- ORCID
- Ushijima, Toshikazu
- Venue
- Nature Reviews Cancer
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 223-231
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999464755
- Cited by
- 483
- References
- 90
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 4 · 2020: 17 · 2019: 17 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 25 · 2014: 26 · 2013: 36 · 2012: 30
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNA methylation, epigenetic modifications, cancer, tumor suppressor, diagnostic biomarkers, prognostic factors, CpG islands
- MeSH terms
- DNA, Neoplasm, Genetic Markers, Humans, Neoplasms, Promoter Regions, Genetic, Genes, Tumor Suppressor, Genome, CpG Islands, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.